3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasm Malignant Female
1
Interventions
Letrozole
34
Fulvestrant
31
Specimen Handling
29
ribociclib
22
pembrolizumab
22
Paclitaxel
21
Magnetic Resonance Spectroscopy
20
palbociclib
19
Trastuzumab
19
Anastrozole
19
Carboplatin
18
Capecitabine
18
exemestane
17
abemaciclib
16
Biopsy
16
Tamoxifen
15
pertuzumab
14
trastuzumab deruxtecan
12
Cyclophosphamide
10
Taxes
9
Radiotherapy
8
Goserelin
8
Docetaxel
8
giredestrant
7
Standard of Care
7
130-nm albumin-bound paclitaxel
7
inavolisib
6
eribulin
6
elacestrant
6
atezolizumab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Immunophenotyping
×
Breast
×
30 days
×
Clear all
NCT04198727
2026-06-02
DPDMAX
Centre Antoine Lacassagne
Phase 2
Active not recruiting
155 enrolled